Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Identifying super-responders to benralizumab in severe asthma

David J Jackson, Tim Harrison, Francesco Menzella, Vivian H Shih, Annie Burden, Esther Garcia Gil
European Respiratory Journal 2021 58: PA3734; DOI: 10.1183/13993003.congress-2021.PA3734
David J Jackson
1Guy's Severe Asthma Center, Guy’s & St. Thomas’ NHS Trust; Asthma UK Centre, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: david.jackson@gstt.nhs.uk
Tim Harrison
2Nottingham Respiratory NIHR BRC, University of Nottingham; AstraZeneca, Nottingham; Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesco Menzella
3Pneumology Unit, Azienda USL di Reggio Emilia-IRCCS, Reggio Emilia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vivian H Shih
4AstraZeneca, Gaithersburg, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annie Burden
5AstraZeneca, Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esther Garcia Gil
6AstraZeneca, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 58 no. suppl 65
DOI 
https://doi.org/10.1183/13993003.congress-2021.PA3734

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Published online November 25, 2021.

Copyright & Usage 
Copyright ©the authors 2021

Author Information

  1. David J Jackson1⇑,
  2. Tim Harrison2,
  3. Francesco Menzella3,
  4. Vivian H Shih4,
  5. Annie Burden5 and
  6. Esther Garcia Gil6
  1. 1Guy's Severe Asthma Center, Guy’s & St. Thomas’ NHS Trust; Asthma UK Centre, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom
  2. 2Nottingham Respiratory NIHR BRC, University of Nottingham; AstraZeneca, Nottingham; Cambridge, United Kingdom
  3. 3Pneumology Unit, Azienda USL di Reggio Emilia-IRCCS, Reggio Emilia, Italy
  4. 4AstraZeneca, Gaithersburg, United States of America
  5. 5AstraZeneca, Cambridge, United Kingdom
  6. 6AstraZeneca, Barcelona, Spain
  1. David J Jackson, Guy's Severe Asthma Center, Guy’s & St. Thomas’ NHS Trust; Asthma UK Centre, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom. E-mail: david.jackson{at}gstt.nhs.uk

Article usage

Article usage: November 2021 to June 2022

AbstractFullPdf
Nov 20213700
Dec 20218000
Jan 20224500
Feb 20224400
Mar 20224600
Apr 20223600
May 20223400
Jun 20223600

Altmetrics

Previous
Back to top
Vol 58 Issue suppl 65 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Identifying super-responders to benralizumab in severe asthma
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Identifying super-responders to benralizumab in severe asthma
David J Jackson, Tim Harrison, Francesco Menzella, Vivian H Shih, Annie Burden, Esther Garcia Gil
European Respiratory Journal Sep 2021, 58 (suppl 65) PA3734; DOI: 10.1183/13993003.congress-2021.PA3734

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Identifying super-responders to benralizumab in severe asthma
David J Jackson, Tim Harrison, Francesco Menzella, Vivian H Shih, Annie Burden, Esther Garcia Gil
European Respiratory Journal Sep 2021, 58 (suppl 65) PA3734; DOI: 10.1183/13993003.congress-2021.PA3734
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Real-life impact of weight in severe eosinophilic asthma patients treated with benralizumab
  • Heterogeneous response of airway eosinophilia to biologics in severe asthma patients
  • Eosinophils in bronchial biopsy predict functional response to biological therapy in severe asthma
Show more Airway pharmacology and treatment

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society